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Background: Mesenchymal stem cells (MSCs) have been proposed as autologous therapy for
inflammatory diseases in neonates. MSCs from umbilical cord Wharton’s jelly (WJ-MSCs) are
accessible, with high proliferative capacity. The effects of WJ-MSCs on neutrophil activity in
neonates are not known. We compared the effects of WJ-MSCs on apoptosis and the expression
of inflammatory, oxidant, and antioxidant mediators in adult and neonatal neutrophils.
Methods: WJ-MSCs were isolated, and their purity and function were confirmed by flow
cytometry. Neutrophils were isolated from cord and adult blood by density centrifugation. The
effects of neutrophil/WJ-MSC co-culture on apoptosis and gene and protein expression were
measured.
Results: WJ-MSCs suppressed neutrophil apoptosis in a dose-dependent manner. WJ-MSCs
decreased gene expression of NADPH oxidase-1 in both adult and neonatal neutrophils, but
decreased heme oxygenase-1 and vascular endothelial growth factor and increased catalase and
cyclooxygenase-2 in the presence of lipopolysaccharide only in adult cells. Similarly, generation of interleukin-8 was suppressed in adult but not neonatal neutrophils. Thus, WJ-MSCs
dampened oxidative, vascular, and inflammatory activity by adult neutrophils, but neonatal
neutrophils were less responsive. Conversely, Toll-like receptor-4, and cyclooxygenase-2 were
upregulated in WJ-MSCs only in the presence of adult neutrophils, suggesting an inflammatory
MSC phenotype that is not induced by neonatal neutrophils.
Conclusion: Whereas WJ-MSCs altered gene expression in adult neutrophils in ways suggesting anti-inflammatory and antioxidant effects, these responses were attenuated in neonatal cells.
In contrast, inflammatory gene expression in WJ-MSCs was increased in the presence of adult
but not neonatal neutrophils. These effects should be considered in clinical trial design before
WJ-MSC-based therapy is used in infants.
Keywords: inflammation, umbilical cord, apoptosis, neutrophil, mesenchymal stem cells
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Mesenchymal stem cells (MSCs) are multipotent progenitor cells that mediate immune
tolerance in recipient hosts. These cells are commonly isolated from bone, blood, and
adipose tissues, as well as from umbilical cord Wharton’s jelly. They home to damaged
tissues and contribute to their repair by secretion of cytokines, chemokines, and extracellular matrix proteins.1 Bone marrow-derived (BM)-MSCs, the most commonly studied
MSCs, are also highly immunosuppressive both in vitro and in vivo in animal models.2,3
BM-MSCs modulate immune responses by dendritic cells, lymphocytes, neutrophils, and
monocytes, in part through the release of cytokines and lipid mediators.4 These cells also
inhibit apoptosis and reduce the formyl-methionyl-leucyl-phenylalanine-induced respiratory burst in neutrophils by constitutive release of interleukin (IL)-6.5 Some evidence
1
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suggests that immunosuppression by BM-MSCs is dependent
on their expression of the adhesion molecules, ie, intercellular
adhesion molecule-1 (ICAM-1) and vascular cell adhesion
molecule-1, indicating that cell-to-cell contact is required.3
However, the mechanisms of immunosuppression by MSCs
are not known.
MSCs may have therapeutic utility in neonates, who are
susceptible to inflammatory diseases, such as bronchopulmonary dysplasia. However, the invasiveness of bone marrow
aspiration and the age-dependent degradation in quantity and
quality of BM-MSCs limit their clinical potential. Human
umbilical cord Wharton’s jelly (WJ) provides an alternative
source of MSCs that exhibit high proliferative capacity and
multidifferentiation potential.6 These cells are abundant and
accessible, and when compared with MSCs from adult bone
marrow or adipose tissue, WJ-MSCs are more robustly proliferative and immunosuppressive.7 Of note, these cells can be
expanded from the umbilical cord at the time of birth, raising
the possibility of autologous treatment of newborns.
Neutrophils are nonproliferative circulating phagocytes
that produce reactive oxygen intermediates and inflammatory
cytokines, and also promote vascular remodeling by secretion
of angiogenic growth factors.8 However, prolonged activation
of these cells following hypoxic or infectious insults has been
implicated in chronic inflammatory diseases associated with
alterations in tissue architecture, such as bronchopulmonary
dysplasia.9 Current therapies to ameliorate neutrophil cytotoxicity have not been completely effective in treating or
preventing these conditions. WJ-MSCs have been proposed
as cell-based prophylaxis or treatment for neonatal inflammatory diseases.10 However, the effects of WJ-MSCs on
neonatal neutrophil activity are not known.
In the current studies, we compared the dose-dependent
effects of WJ-MSCs on apoptosis and inflammatory function in neonatal and adult neutrophils. We hypothesized that
WJ-MSCs would downregulate expression of oxidant and
inflammatory mediators, and increase antioxidant expression
in neutrophils. Experiments were performed in the presence
or absence of IL-6 or ICAM-1 (CD54) blocking antibodies
to investigate the possibility that these effects are mediated
by soluble mediators or cell contact, respectively.3,11

Materials and methods
Reagents
Dulbecco’s Modified Eagle’s Medium, phosphate-buffered
saline, and bacterial lipopolysaccharide (serotype 0128:B12)
were purchased from Sigma Chemical Company (St Louis,
MO, USA). Dextran was from ThermoFisher (Fairlawn,
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NJ, USA). Ficoll-Paque was from GE Healthcare (Piscataway,
NJ, USA), and heat inactivated fetal bovine serum was
from Biosera US (Kansas City, MO, USA). Annexin
V-APC, 7-actinomycin D (7-AAD) and cytometric bead
array flex sets were from BD Biosciences (San Jose, CA,
USA). RNeasy RNA purification kits were purchased from
Qiagen (Chatsworth, CA, USA). Primers for real time polymerase chain reaction were obtained from Integrated DNA
Technologies, Inc. (Coralville, IA, USA) and Power SYBR
green master mix from Applied Biosystems (Foster City, CA,
USA). Anti-human IL-6 and anti-human CD54 (ICAM-1)
were from eBioscience (San Diego, CA, USA).

Subjects
These studies were approved by the institutional review
board of Robert Wood Johnson Medical School. Umbilical
cord blood samples were collected at the time of delivery of
healthy term newborns ($37 weeks gestation) by elective
cesarean section prior to labor, with tissue-specific informed
consent. Subjects with clinical evidence of chorioamnionitis,
funisitis, or other perinatal infections were excluded. For
comparison, neutrophils were isolated from peripheral venous
blood of healthy adult volunteers.

WJ-MSC isolation
WJ-MSCs from nine infants were isolated by peeling the
outer membrane of the umbilical cord and dissecting out the
arteries and vein, as previously described.12 WJ was cut into
1–3 mm pieces and placed in 10 cm tissue culture dishes.
After drying (15 minutes), Dulbecco’s Modified Eagle’s
Medium + 10% fetal bovine serum was added. Half of the
medium was changed on day 5, and all media were changed
every 3 days subsequently. Adherent cells reached confluence
after 10–12 days. Cells from each subject were treated as a
new cell line and tested for purity and expression of characteristic MSC markers by flow cytometry. Similar to previous
reports,1–3 all nine lines expressed CD105, CD73, and CD90,
but not CD45, CD34, or CD31. All experiments were performed no later than passage five, to maintain consistency.

Neutrophil isolation and co-culture
Polymorphonuclear neutrophils (PMN) were isolated by
dextran sedimentation, Ficoll gradient centrifugation, and
hypotonic lysis. Cells were resuspended in Dulbecco’s
Modified Eagle’s Medium containing 10% fetal bovine
serum (1×106 cells/mL). Neutrophil suspensions were incubated with adherent WJ-MSCs in 24-well plates at 37°C, at
WJ-MSC to neutrophil ratios of 1:20–1:640 for apoptosis
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studies and 1:20 for analysis of gene and protein expression.
Cell viability (defined by absence of uptake of 7-AAD fluorescence dye) was .97% in all experiments.

Measurement of neutrophil apoptosis
After 24 hours in co-culture with WJ-MSCs, neutrophils
were washed out of the wells, pelleted, and resuspended in
phosphate-buffered saline at 1×107 cells/mL. Triplicate aliquots of cells (100 mL) were then incubated with Annexin
V-APC (1:20) and 7-AAD (1:10; 15 minutes, room temperature). The remaining cells were lysed for measurement of gene
expression, as described below. Cells were analyzed by flow
cytometry on a FACSArray Bioanalyzer (BD Biosciences).
Neutrophils were identified based on forward scatter and
side scatter characteristics, and all analyses were performed
on this population. Viable neutrophils were defined as those
not taking up either Annexin V or 7-AAD. Necrotic cells
were defined as those taking up only 7-AAD, and apoptotic
cells as those binding Annexin V. Quadrant boundaries were
determined using unstained, as well as positive control cells
stained with either 7-AAD or Annexin V-APC, and statistics
were performed based on the relative cell numbers in these
quadrants.

Gene expression

PMN were incubated with WJ-MSCs (WJ-MSC + PMN, 1:20)
or medium control (PMN) for 24 hours, in the presence or
absence of lipopolysaccharide (1 µg/mL) and antibodies to
ICAM-1 or IL-6 (1 µg/mL). Neutrophils and WJ-MSCs were
separated after co-culture by adherence. Nonadherent neutrophils were harvested from the co-culture supernatant, and their
purity was confirmed by morphology. Viable WJ-MSCs were
identified as adherent to the culture plate after two washes with
phosphate-buffered saline. Absence of residual neutrophils
and WJ-MSC morphology were confirmed by microscopy.
Total RNA was extracted from neutrophils or WJ-MSCs, complementary DNA generated, and gene expression quantified by
real-time polymerase chain reaction using RT2 qPCR master
mix (Qiagen) and amplified using a Stratagene MX300p instrument, with β-actin as standard. Full-length coding sequences
were obtained from GenBank™. Primers were designed using
Primer Express software. Forward and reverse primers used
were: NOX-1, 5′-CCTTGCACCGGTCATTCTTT-3′
a n d 5 ′ - C G G TA A A A C C G G A G G AT C C T- 3 ′ ;
C O X - 2 , 5 ′ - G C C T G AT G AT T G C C C G A C T- 3 ′
a n d 5 ′ - G C T G G C C C T C G C T TAT G AT C T- 3 ′ ;
H O - 1 , 5 ′ - G C T C A A A A A G AT T G C C C A G A - 3 ′
a n d 5 ′ - G C G G T A G A G C T G C T T G A A C T- 3 ′ ;
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c a t a l a s e , 5 ′ - C G G AG AT T C A AC AC T G C C A A - 3 ′
a n d 5 ′ - G A AT G C C C G C A C C T G A G TA A - 3 ′ ;
VEGF, 5 ′-GGCGTCGCACTGAAACTTTT-3′ and
5′-TCCGAAGCGAGAACAGCC-3′; TLR4,
5 ′ - C C A G A G C C G C T G G T G T A T C T- 3 ′ a n d
5′-AACTGCCAGGTCTGAGCAATCT-3′; β-actin,
5 ′ - A A A G A C C T G TA C G C C A A C A C - 3 ′ a n d
5′-GTCATACTCCTGCTTGCTGAT-3′.

Protein expression
Supernatants from 24-hour cultures of neutrophils and/or WJMSCs were incubated with premixed flex set beads coated
with antibodies to IL-8, macrophage inflammatory protein
(MIP)-1β, and ICAM-1 for 1 hour in 96-well filtration plates.
Premixed phycoerythrin-labeled detection reagent was then
added to the wells, and the plates incubated at room temperature in the dark for 2 hours. Bead/protein complexes were
then washed and analyzed for fluorescence intensity using
a BD FACSArray Bioanalyzer. Data were analyzed using
BD FCAP software (version 2.0) with five parameter curve
fitting. Measurements from co-cultures (observed) were
compared with the sum of the measurements from cultures
of neutrophils and WJ-MSCs alone (expected) and data are
presented as the mean ± 95% confidence interval.

Statistical analysis
Data were analyzed using Statistica version 5.5 (StatSoft,
Inc., Tulsa, OK, USA). The effects of treatments were
compared pairwise by Student’s t-test.

Results
WJ-MSCs suppressed neutrophil apoptosis in a dose-dependent
manner (Figure 1). WJ-MSC to neutrophil ratios greater than
1:80 resulted in significant decreases in neutrophil apoptosis
over 24 hours, in both adult and neonatal cells, with optimal
efficacy at a WJ-MSC to neutrophil ratio greater than 1:40.
In order to have enough cells for gene expression and protein
assays, a ratio of 1:20 was chosen for all experiments. As
previously reported,13 apoptosis was significantly reduced in
neonatal neutrophils when compared with adult cells, but this
difference was not sustained in the presence of WJ-MSCs.
Incubation with IL-6 or ICAM-1 blocking antibodies did not
affect apoptosis (not shown).
NADPH oxidase-1 (NOX-1) is a membrane-bound
enzyme that is important in generating the superoxide anion
that drives respiratory burst activity in neutrophils. We
found that WJ-MSCs suppressed NOX-1 expression in both
adult and neonatal neutrophils (Figure 2). WJ-MSCs also
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Figure 1 Effects of WJ-MSCs on neutrophil apoptosis.
Notes: Adult and neonatal neutrophils were incubated with WJ-MSCs at varying ratios for 24 hours and then analyzed for apoptosis by flow cytometry using BD FACSArray
quadrant and two-dimensional histogram statistics based on relative fluorescence. Each bar represents the mean ± standard error (n=3–8). +Significantly different (P,0.05)
from adult; *significantly different (P,0.05) from untreated control (0).
Abbreviation: MSCs, mesenchymal stem cells; WJ-MSCs, MSCs derived from Wharton’s jelly.

 arkedly induced expression of the antioxidant enzyme
m
catalase and suppressed expression of heme oxygenase-1
(HO-1) and vascular endothelial growth factor (VEGF), but
these changes were significant only in adult cells. Effects of
WJ-MSCs on neutrophil expression of the NOX-1 gene were
decreased by antibodies to IL-6 or ICAM-1, catalase gene
by anti-ICAM-1 only, VEGF by anti-IL-6 only, and HO-1 by
neither antibody.
Lipopolysaccharide induced Toll-like receptor-4 (TLR4)
expression in adult but not neonatal neutrophils (Figure 3A).
These responses were not affected by co-culture with WJMSCs. Some previous reports have suggested that WJ-MSCs
may be distinguished from other MSCs by their hyporesponsiveness to lipopolysaccharide associated with low expression
of TLR4.14 Consistent with this, we found that lipopolysaccharide did not induce TLR4 in WJ-MSCs (Figure 3B). In
contrast, co-culture with adult neutrophils markedly increased
TLR4 expression in WJ-MSCs. Cyclooxygenase-2 (COX-2),
which catalyzes the production of inflammatory eicosanoids
in neutrophils, is regulated in part by TLR4.15 We found that
lipopolysaccharide markedly induced COX-2 expression
(20-fold) in adult neutrophils (Figure 3A). COX-2 expression in adult neutrophils further increased (60-fold) in the
presence of both lipopolysaccharide and WJ-MSCs. As for
TLR4, neonatal neutrophils were not affected by lipopolysaccharide and/or WJ-MSCs. While WJ-MSCs did not express
COX-2 in response to lipopolysaccharide or to co-culture
with neutrophils, the combination of lipopolysaccharide and

4
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adult neutrophils markedly induced generation of COX-2
(40-fold; Figure 3B).
Both neutrophils and WJ-MSCs constitutively produced
IL-8 (Table 1). Consistent with previous reports, production
of IL-8 was markedly decreased in neonatal neutrophils when
compared with adult neutrophils. The combined generation of
IL-8 by neutrophils and WJ-MSCs in co-culture was significantly decreased in adult but not neonatal cells. In contrast,
expression of MIP-1β, another chemokine associated with
neutrophil recruitment, by neutrophils and WJ-MSCs was not
affected by co-culture of these cells. Expression of ICAM-1
by neutrophils and WJ-MSCs was also not significantly
affected by co-culture.

Discussion
Our finding that WJ-MSCs suppress neutrophil apoptosis
in a dose-dependent manner indicates that the physiologic
effects of WJ-MSCs are similar in some respects to those
demonstrated by BM-MSCs. Previous reports have shown
that BM-MSCs protect adult neutrophils from apoptosis by
triggering STAT-3 signaling5 or by decreasing expression of
Bax, a proapoptotic member of the Bcl-2 family.16 BM-MSCs
secrete mediators (VEGF, transforming growth factor-β) that
promote fibroblast activation, angiogenesis, and alteration
of tissue architecture, ie, processes that may be facilitated
by neutrophils.17 Thus, prolonged viability of neutrophils in
the presence of MSCs may facilitate MSC-mediated tissue
repair. Our findings also suggest that the immunomodulatory
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NOX-1

+

Adult
Neonatal

2

1
*

*

0

Gene expression (fold-change)

50
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*
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+
0
2

HO-1

1

*

0
1.5
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+

1

0.5
*
0

PMN

WJ-MSCs
+ PMN

WJ-MSCs WJ-MSCs
+ PMN
+ PMN
+ α-ICAM-1 + α-IL-6

Figure 2 Expression of VEGF, catalase, HO-1, and NOX-1 in neutrophils
exposed to WJ-MSCs.
Notes: Adult and neonatal neutrophils were incubated with WJ-MSCs (WJ-MSCs +
PMN, 1:20) or medium control (PMN) for 4 hours, in the presence or absence of
neutralizing antibodies to ICAM-1 or IL-6 (1 µg/mL). Total RNA was extracted,
complementary DNA generated, and gene expression quantified by real-time
polymerase chain reaction. Results were normalized to β-actin expression.
Each bar represents the mean ± standard error (n=5–7). *Significantly different
(P,0.05) from control; +significantly different (P,0.05) from MSCs + PMN.
Abbreviations: NOX-1, NADPH oxidase-1; HO-1, heme oxygenase-1; VEGF,
vascular endothelial growth factor; MSCs, mesenchymal stem cells; WJ-MSCs,
MSCs derived from Wharton’s jelly; PMN, polymorphonuclear neutrophils; IL-6,
interleukin-6; ICAM-1, intercellular adhesion molecule-1.
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effects of WJ-MSCs do not occur by facilitating neutrophil
clearance, but most likely by decreasing their activity.
To investigate this, we next quantified the effects of
WJ-MSCs on the expression of pro-oxidant and antioxidant
enzymes in neutrophils. Neutrophils exert their bactericidal
and inflammatory activity, in part, by the release of reactive
oxygen intermediates, but prolonged neutrophil activity can
cause cytotoxicity.18 NOX-1 is expressed in these cells, mediating the transfer of electrons to molecular oxygen to produce
the superoxide anion. We found that WJ-MSCs suppressed
NOX-1 activity in both adult and neonatal neutrophils, which
may serve to modulate oxidative activity and ameliorate
potential tissue injury. WJ-MSCs also induced expression
of the antioxidant catalase, but only in adult neutrophils.
Catalase protects cells from reactive oxygen intermediates
by catalyzing the decomposition of hydrogen peroxide to
water and oxygen, and its basal expression is decreased in
neonatal neutrophils. Our observation that catalase is further
upregulated in adult cells is consistent with previous reports
that MSCs ameliorate hepatic injury by upregulating catalase expression in the liver.19 Upregulation of catalase may
protect adults from neutrophil-mediated cytotoxicity in the
presence of WJ-MSCs, but neonates appear to be resistant
to this antioxidant effect.
WJ-MSCs also significantly decreased expression of the
anti-inflammatory enzyme HO-1 in adult neutrophils but
not in neonatal cells. HO-1 exerts anti-inflammatory effects
by upregulating IL-10 and IL-1R antagonist expression.20
This results in decreased neutrophil rolling and adhesion,
as well as transmigration of these cells to inflammatory
sites. Thus, the relative preservation of HO-1 activity in
neonatal neutrophils exposed to WJ-MSCs may be a marker
of preserved immune responses. Similarly, WJ-MSCs suppressed VEGF gene expression in adult, but not neonatal
cells. VEGF is important in physiologic angiogenesis that
drives tissue differentiation and growth.8 Taken together, the
hyporesponsiveness of neonatal neutrophils suggests that
interactions between WJ-MSCs and neutrophils in neonates
may be characterized by sustained immune activity and ongoing tissue modeling and repair, whereas those in adult cells
are predominantly characterized by suppression of oxidant
activity and immunosuppression.
In contrast with earlier reports indicating that ICAM-1
is important in mediating the immunosuppressive effects
of BM-MSCs,3 antibodies to ICAM-1 did not alter the
effects of WJ-MSCs on apoptosis or expression of antioxidant or inflammatory mediators in neonatal neutrophils.
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+ PMN
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Figure 3 Expression of TLR-4 and COX-2 in neutrophils and WJ-MSCs.
Notes: (A) Adult and neonatal neutrophils were incubated in medium control (PMN), LPS (1 µg/mL) and/or WJ-MSCs (WJ-MSCs to neutrophils, 1:20) (B) WJ-MSCs were
incubated in medium control (MSCs), with LPS (1 µg/mL), and/or adult or neonatal neutrophils (WJ-MSCs to neutrophils, 1:20). Total RNA was extracted from neutrophils
(A) or WJ-MSCs (B), complementary DNA generated, and gene expression quantified by real-time polymerase chain reaction. Results were normalized to β-actin expression.
Each bar represents the mean ± standard error (n=5–7). *Significantly different (P,0.05) from PMN control; +significantly different (P,0.05) from PMN + LPS (A) or MSCs +
LPS (B).
Abbreviations: COX-2, cyclooxygenase-2; MSCs, mesenchymal stem cells; WJ-MSCs, MSCs derived from Wharton’s jelly; PMN, polymorphonuclear neutrophils; LPS,
lipopolysaccharide; TLR4, Toll-like receptor-4.

Thus, ICAM-mediated cell contact is not likely an obligatory pathway for these effects. It is possible that this represents a mechanistic distinction between BM-MSCs and
WJ-MSCs. Alternatively, our findings are consistent with
previous studies reporting that the biologic effects of MSCs
are mediated by soluble mediators, rather than direct contact.21,22 However, blocking antibodies to IL-6 also had no

effect on WJ-MSC-mediated changes in neonatal neutrophil
apoptosis or secretory activity. It is possible that MSCs exert
paracrine effects via membrane-bound exosomes containing multiple soluble mediators affecting inflammatory and
oxidative activity.23
TLR4 expression in neutrophils was upregulated by
lipopolysaccharide in adult neutrophils, and this was not

Table 1 Production of inflammatory mediators by neutrophils and WJ-MSCs
Neutrophils,
mean (95% CI)

WJ-MSCs mean (95% CI)

Neutrophil + WJ-MSCs
(expected) mean (95% CI)

Neutrophil + WJ-MSCs
(observed) mean (95% CI)

MIP-1β (pg/mL)
IL-8 (ng/mL)
ICAM-1 (pg/mL)
Neonatal

123 (42, 203)

17 (14, 20)

140 (56, 223)

72 (32, 112)

12 (5, 20)
89 (43, 134)

35 (11, 57)
144 (101, 187)

47 (16, 77)
233 (144, 321)

9 (3, 16)**
205 (142, 268)

MIP-1β (pg/mL)
IL-8 (ng/mL)
ICAM-1 (pg/mL)

66 (14, 119)

21 (15, 26)

87 (29, 145)

126 (52, 200)

3 (1, 5)
102 (46, 157)

24 (1, 48)
143 (50, 236)

27 (2, 53)
230 (96, 393)

29 (7, 50)
184 (84, 284)

Adult

Note: **Significantly different (P,0.05) from neutrophil + WJ-MSCs (expected).
Abbreviations: CI, confidence interval; MSCs, mesenchymal stem cells; WJ-MSCs, MSCs derived from Wharton’s jelly; IL, interleukin; ICAM-1, intercellular adhesion
molecule-1; MIP-1β, macrophage inflammatory protein-1β.
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affected by WJ-MSCs. Previous studies have suggested that
WJ-MSCs are distinct from BM-MSCs in that they do not
express TLR4 and are nonresponsive to lipopolysaccharide.24
However, co-culture with adult neutrophils markedly upregulated expression of TLR4 in WJ-MSCs. This may represent
a biologically relevant trigger for inflammation in adults,
since TLR4-primed MSCs can differentiate into a phenotype
(“MSC1”) characterized by secretion of proinflammatory
mediators.25 This pathway appears to be developmentally
impaired in neonatal neutrophils, which do not upregulate
TLR4 expression and do not induce it in WJ-MSCs. COX-2
expression is regulated in part by TLR4.15 BM-MSCs bind
lipopolysaccharide via surface TLR4 receptors, initiating a
signaling cascade involving sequential activation of NF-κB
and upregulation of COX-2 production.26 We found that gene
expression of COX-2 by WJ-MSCs is markedly upregulated
in the presence of adult neutrophils and lipopolysaccharide,
but not of either of those alone. Similarly, COX-2 is induced
in adult neutrophils by lipopolysaccharide, and significantly
further increased by WJ-MSCs. Our findings suggest that
WJ-MSCs and neutrophils generate prostaglandins or
other eicosanoids under inflammatory conditions, but that
these signaling pathways are developmentally impaired in
neonates.
We also found that WJ-MSCs and adult neutrophils in
co-culture generate significantly less IL-8 than they do alone.
IL-8 is a chemokine that activates neutrophil calcium mobilization and chemotaxis,27,28 so this may represent a mechanism
for immunomodulation by WJ-MSCs. In contrast, WJ-MSCs
did not affect the generation of ICAM-1 or the chemokine
MIP-1β in either adult or neonatal neutrophils. ICAM-1
mediates transendothelial migration of neutrophils, and
MIP-1β is secreted in large quantities by lipopolysaccharideactivated neutrophils.29 Our finding that WJ-MSCs do not
affect expression of IL-8, ICAM-1, or MIP-1β in neonatal
neutrophils suggests that WJ-MSCs may not suppress neutrophilic inflammation in this population as anticipated.

Conclusion
Hospitalized premature neonates are susceptible to diseases characterized by excessive inflammation, including
bronchopulmonary dysplasia, and MSC-based therapies
are thought to have potential in preventing or ameliorating these conditions. Animal studies of such therapies
have shown efficacy in conditions including sepsis30 and
acute lung injury,31 and initial trials in human neonates32
and adults33 have indicated feasibility and possible efficacy in bronchopulmonary dysplasia and chronic lung
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disease, respectively. In the current studies, WJ-MSCs
suppressed apoptosis and dampened oxidative, vascular,
and inflammatory activity by adult neutrophils, but neonatal neutrophils were less responsive. Conversely, TLR4
and COX-2 were upregulated in WJ-MSCs only when
they were co-cultured with adult neutrophils, suggesting
an inflammatory MSC phenotype that is not induced by
neonatal neutrophils. Moreover, WJ-MSCs suppressed
apoptosis of both adult and neonatal cells. In summary,
WJ-MSCs may alter neutrophilic inflammation in adults
and neonates via pathways that are distinct. These effects
should be carefully considered and tested in clinical trials
before WJ-MSC-based-therapy is promoted for prophylaxis
or treatment in infants.
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